Welcome to Partnering with AstraZeneca
Improving health is one of the toughest challenges facing society today. As a global pure-play biopharmaceutical company, AstraZeneca has a key contribution to make by providing innovative medicines for some of the world’s most serious diseases.
Why partnering is important to us
We cannot meet all the challenges alone. Driven by our philosophy that health connects us all, we believe that by forming synergistic partnerships, we will be more successful in delivering the medicines that people really need and value.
Shaun Grady discusses our partnering strategy
In an interview for PharmaTV, AstraZeneca’s VP Strategic Partnering and Business Development, Shaun Grady, discusses our partnering strategy.
What we offer partners
We bring a broad range of skills and resources to every partnership including:
leading discovery, development, and commercialisation capabilities that are global in nature and coupled with local experience and knowledge.
Our partnering process
We are committed to working with our collaborators to create tailored partnerships that are structured to best achieve our mutual goals.
Our areas of interest
In addition to our 6 core therapeutic indications and personalised healthcare and biomarkers, we are also interested in discussing new opportunities outside our core areas as well as science and technologies that will complement or enhance our current competencies.
Talk to us
If you would like to begin a discussion about partnering, we look forward to talking and starting the process